Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Boman Dhabhar"'
Autor:
Tarini Prasad Sahoo, Chirag Desai, Shyam Agarwal, Amit Rauthan, Boman Dhabhar, Ghanshyam Biswas, Sandeep Batra, Rajat Saha, Arun Philip, Vijay Agarwal, Palanki Satya Dattatreya, PN Mohapatra, Chetan Deshmukh, Sagar Bhagat, Saiprasad Patil, Hanmant Barkate
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract In advanced Renal Cell Carcinoma (aRCC), systemic therapy is the mainstay of treatment, with no or little role for surgery in these patients. Tyrosine kinase inhibitors (TKIs) and immune-oncological (IOs) therapies, either alone or in combin
Externí odkaz:
https://doaj.org/article/63bb52e8c3304decb700ec7898d8f205
Autor:
Anant Ramaswamy, Kripa Bajaj, Vineet Talwar, Kumar Prabhash, Ullas Batra, Boman Dhabhar, Mansi Sharma, Nikhil Ghadyalpatil, Satish CT, Gautam Goyal, Javvid Muzamil, Amit Bhatt, Parveen Jain, Anantbhushan Ranade, Mangesh Kamath, Jayant Pundlik Gawande, Ravi Thippeswamy, Jimmy Mirani, Neelesh Reddy, Sandip Ganguly, Sourav Kumar Mishra, Irappa Madabhavi, Shashidhara HP, Soumya Surath Panda, Shekar Patil, Prabhat Bhargava, Vikas Ostwal
Publikováno v:
South Asian Journal of Cancer, Vol 11, Iss 01, Pp 024-030 (2022)
Abstract Vikas Ostwal Background Ramucirumab is considered a standard of care as second-line therapy (CT2) in advanced gastric cancers (AGCs). The aim of this study was to assess practice patterns and outcomes with ramucirumab among Indian patients
Externí odkaz:
https://doaj.org/article/fd744a65e57f4351b325109ee0646245
Autor:
Nihar Mehta, Ajit Desai, Bharat Shivdasani, Satyajeet Suryawanshi, A.B. Mehta, A. Behranwala, Boman Dhabhar
Publikováno v:
Indian Heart Journal, Vol 64, Iss 4, Pp 416-419 (2012)
Primary spindle cell sarcoma of the left atrium is an extremely rare tumour. Surgical excision is the mainstay of treatment since it responds poorly to chemotherapy or radiotherapy. In spite of all the treatment, the prognosis remains poor due to ina
Externí odkaz:
https://doaj.org/article/04e6149da82f4f74bb70eda272f54882
Autor:
Boman, Dhabhar
Publikováno v:
Breast Cancer: Targets and Therapy. 14:163-173
Chemotherapeutic agents, endocrine therapy and radiotherapy used in the management of breast cancer are known to cause decreased bone mineral density, and thus, increased incidence of fractures. A majority (~60%) of the breast cancer patients in Indi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4abb314d700c87e938aeaa25cac6a07
https://doi.org/10.2147/bctt.s353332
https://doi.org/10.2147/bctt.s353332
Publikováno v:
Indian journal of cancer. 59
EGFR-TKIs have changed the landscape of metastatic NSCLC treatment with a significant improvement in survival of EGFRm patients compared to wild-type EGFR. Even with the newer third generation EGFR TKIs like, Osimertinib, which has proven efficacy ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62b874358e8733a4a73d7edbb0894064
https://pubmed.ncbi.nlm.nih.gov/35343192
https://pubmed.ncbi.nlm.nih.gov/35343192
Autor:
Amit Bhatt, Parveen Jain, Mangesh Kamath, Sandip Ganguly, Soumya Surath Panda, Jimmy Mirani, Anantbhushan Ranade, Boman Dhabhar, Neelesh Reddy, Shekar Patil, Anant Ramaswamy, Kripa Bajaj, Ravi Thippeswamy, Prabhat Bhargava, Vikas Ostwal, SK Mishra, Mansi Sharma, Irappa Madabhavi, Vineet Talwar, C T Satish, Ullas Batra, N. Ghadyalpatil, Javvid Muzamil, H P Shashidhara, Gautam Goyal, Jayant Pundlik Gawande, Kumar Prabhash
Publikováno v:
South Asian Journal of Cancer (2021)
Background Ramucirumab is considered a standard of care as second-line therapy (CT2) in advanced gastric cancers (AGCs). The aim of this study was to assess practice patterns and outcomes with ramucirumab among Indian patients with AGCs. Materials an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eea41e935a5e90880b05d46adb95e0d
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1728980
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1728980
Publikováno v:
Indian Journal of Case Reports. 5:64-66
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::266dca1ed5ebc20f000e75f7ded69e06
https://doi.org/10.32677/ijcr.2019.v05.i01.022
https://doi.org/10.32677/ijcr.2019.v05.i01.022
Autor:
Jun Guo, John Wen-Cheng Chang, Sang Joon Shin, Virote Sriuranpong, Richard Quek, Anthony Ying, Si Lu, Maria Luisa T. Abesamis Tiambeng, Naoya Yamazaki, Chia-Yen Hung, Huu Sau Nguyen, Gwo Fuang Ho, Nugroho Prayogo, Boman Dhabhar
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 13:423-427
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4488bd5e75da73667876d50bc435311
https://doi.org/10.1111/ajco.12670
https://doi.org/10.1111/ajco.12670
Publikováno v:
Apollo Medicine. 12:54-56
Introduction Posterior reversible encephalopathy syndrome (PRES), is a syndrome characterized by headache, confusion, seizures and visual loss, which was first described in 1996 by Judy Hinchey. The cause of PRES is not yet understood. We report a ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a24b6c685124f107818830c085c4dc3c
https://doi.org/10.1016/j.apme.2015.02.002
https://doi.org/10.1016/j.apme.2015.02.002
Autor:
Rohit Kumar, Keechilat Pavithran, Sameer Kaul, S.P. Somashekhar, P S Sridhar, Amit Rauthan, Amit Agarwal, Chandragouda Dodagoudar, Boman Dhabhar, Hari Goyal, Ashish Kumar Singh, Satheesh Chiradoni Thungappa
Publikováno v:
Journal of Clinical Oncology. 36:e18106-e18106
e18106Background: Management of advanced differentiated thyroid cancer refractory to radio-iodine (RAI) has taken a new turn with the results of SELECT trial. Physicians are learning to use lenvati...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be84b5db4b20ec4f09dd37289e90cf77
https://doi.org/10.1200/jco.2018.36.15_suppl.e18106
https://doi.org/10.1200/jco.2018.36.15_suppl.e18106